|
Transgene Biotek Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
21.75 Cr.
|
P/BV
|
2.01
|
Book Value (Rs.)
|
1.43
|
|
52 Week High/Low (Rs.)
|
8/3
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
05/12/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -0.09 | -0.09 | -0.79 | -1.37 | -1.38 |
| Diluted EPS (Rs.) | -0.09 | -0.09 | -0.79 | -1.37 | -1.38 |
| Cash EPS (Rs.) | -0.07 | -0.07 | -0.13 | -0.06 | -0.06 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.32 | 1.41 | 1.50 | 2.29 | 2.94 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.32 | 1.41 | 1.50 | 2.29 | 2.94 |
| Revenue From Operations / Share (Rs.) | 0.03 | 0.03 | 0.01 | 0.01 | 0.02 |
| PBDIT / Share (Rs.) | -0.04 | -0.05 | -0.11 | -0.03 | -0.03 |
| PBIT / Share (Rs.) | -0.05 | -0.06 | -0.76 | -1.34 | -1.34 |
| PBT / Share (Rs.) | -0.08 | -0.08 | -0.79 | -1.37 | -1.38 |
| Net Profit / Share (Rs.) | -0.08 | -0.08 | -0.79 | -1.37 | -1.38 |
| NP After MI And SOA / Share (Rs.) | -0.08 | -0.08 | -0.79 | -1.37 | -1.38 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -130.37 | -184.80 | -1592.36 | -290.36 | -153.56 |
| PBIT Margin (%) | -166.12 | -224.09 | -10578.68 | -11737.81 | -5997.29 |
| PBT Margin (%) | -259.34 | -279.05 | -10907.92 | -11999.39 | -6154.34 |
| Net Profit Margin (%) | -259.34 | -279.05 | -10907.92 | -11999.39 | -6154.34 |
| NP After MI And SOA Margin (%) | -259.34 | -279.05 | -10907.92 | -11999.39 | -6154.34 |
| Return on Networth / Equity (%) | -6.74 | -6.11 | -52.85 | -59.86 | -46.92 |
| Return on Capital Employeed (%) | -0.32 | -0.40 | -4.41 | -7.37 | -7.12 |
| Return On Assets (%) | -0.46 | -0.46 | -4.22 | -7.07 | -6.65 |
| Long Term Debt / Equity (X) | 0.60 | 0.47 | 0.43 | 0.27 | 0.20 |
| Total Debt / Equity (X) | 1.45 | 1.31 | 1.15 | 0.69 | 0.50 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.09 | 0.09 | 0.08 | 0.07 | 0.04 |
| Quick Ratio (X) | 0.09 | 0.09 | 0.08 | 0.06 | 0.04 |
| Inventory Turnover Ratio (X) | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -1.40 | -3.36 | -4.84 | -1.11 | -0.97 |
| Interest Coverage Ratio (Post Tax) (%) | -1.78 | -4.08 | -32.13 | -44.87 | -38.19 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 39.62 | 75.67 | 31.98 | 39.35 | 46.01 |
| EV / Net Operating Revenue (X) | 151.97 | 322.14 | 580.49 | 453.84 | 271.36 |
| EV / EBITDA (X) | -116.56 | -174.31 | -36.45 | -156.30 | -176.71 |
| MarketCap / Net Operating Revenue (X) | 97.36 | 262.57 | 342.50 | 315.51 | 204.68 |
| Price / BV (X) | 2.53 | 5.76 | 1.66 | 1.57 | 1.56 |
| Price / Net Operating Revenue (X) | 98.53 | 262.58 | 355.71 | 328.18 | 208.18 |
| EarningsYield | -0.02 | -0.01 | -0.31 | -0.38 | -0.30 |
